Study Of Stubborn Breast Cancers: Group Seeks To Turn Genomic Medicine To Resistant Tumors
Life Technologies said Friday it is applying its gene sequencing prowess to a challenging project: detecting genetic information about breast cancers that show no sign of obvious mutations linked with the disease.
our service is updated everyday, come again
This entry was posted
on Thursday, March 11th, 2010 at 8:49 am and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.